{"id":"W2169923083","doi":"10.1200/jco.2014.55.3628","title":"Gemtuzumab Ozogamicin in Children and Adolescents With De Novo Acute Myeloid Leukemia Improves Event-Free Survival by Reducing Relapse Risk: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":472,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Children's Hospital; Hospital for Sick Children","funders":"National Cancer Institute; National Institutes of Health; Children’s Oncology Group","keywords":"Gemtuzumab ozogamicin; Medicine; Hazard ratio; Internal medicine; Chemotherapy; Induction chemotherapy; Randomized controlled trial; Calicheamicin; Myeloid leukemia; Oncology; Confidence interval; CD33","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001927855,0.0005383547,0.0009114054,0.000194208,0.000155223,0.0004590265,0.0004450428,0.0004793434,0.0009280904],"category_scores_gemma":[0.001513061,0.0002230673,0.0009903394,0.0002124534,0.0005049454,0.0003662079,0.000246696,0.00176453,0.000117267],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007062201,"about_ca_system_score_gemma":0.001055378,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0011133,"about_ca_topic_score_gemma":0.00279182,"domain_scores_codex":[0.9994113,0.0004060912,0.00003261477,0.00004871135,0.00004743964,0.00005374827],"domain_scores_gemma":[0.999022,0.0003176941,0.0003086203,0.00005058949,0.00003678337,0.0002643909],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8142661,0.01365109,0.02976908,0.0008138565,0.003417481,0.0001310371,0.0002570215,0.00253924,0.01045366,0.000311684,0.002299406,0.1220903],"study_design_scores_gemma":[0.67299,0.2419988,0.07095195,0.0001610986,0.002686226,0.0003505496,0.0001009545,0.002545471,0.004094793,0.0002643316,0.003829492,0.00002640951],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9968113,0.002193146,0.0001179335,0.0002392991,0.00003530786,0.0002448329,0.000129635,0.00001214827,0.0002163639],"genre_scores_gemma":[0.995278,0.002447235,0.0007497416,0.0003326822,0.000103346,0.0003575755,0.0003950706,0.000005804205,0.0003305362],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001927855,"threshold_uncertainty_score":0.01019555,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02256369829522603,"score_gpt":0.3769498515563637,"score_spread":0.3543861532611377,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}